scispace - formally typeset
Book ChapterDOI

Unified Parkinson's Disease Rating Scale

Victor R. Preedy, +1 more
- pp 4343-4343
About
The article was published on 2010-01-01. It has received 691 citations till now. The article focuses on the topics: Unified Parkinson's disease rating scale.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Elevated blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in Parkinson's disease

TL;DR: Blood harmane appears to be elevated in Parkinson's disease, and the higher concentration in familial PD suggests that the mechanism may involve genetic factors.
Journal ArticleDOI

Clinical utility of the 6-min walk test for patients with moderate Parkinson's disease.

TL;DR: The convergent validity and clinical utility of the 6-min walk test (6MWT) for patients with moderate Parkinson’s disease (PD) is confirmed, using Hoehn and Yahr stage ratings, UPDRS motor examination score, 6MWT, Timed ‘Up & Go’ test (TUG), 10-m walk test, cadence, and the energy cost of walking (Ec).
References
More filters
Journal ArticleDOI

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

Christopher G. Goetz, +87 more
- 15 Nov 2008 - 
TL;DR: The combined clinimetric results of this study support the validity of the MDS‐UPDRS for rating PD.
Journal ArticleDOI

Colonic inflammation in Parkinson's disease.

TL;DR: Findings provide evidence that enteric inflammation occurs in Parkinson's disease and further reinforce the role of peripheral inflammation in the initiation and/or the progression of the disease.
Journal ArticleDOI

Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease

TL;DR: Although freezing of gait can be improved by low-frequency electrical stimulation of the pedunculopontine nucleus area in some patients with Parkinson's disease, the overall results are disappointing compared to the high levels of expectation raised by previous open label studies.
Journal ArticleDOI

The Clinically Important Difference on the Unified Parkinson's Disease Rating Scale

TL;DR: In this paper, a cross-sectional analysis of the CIDs for UPDRS total and motor scores was performed on patients with Parkinson disease (PD) using distribution-and anchor-based approaches based on the following external standards: disability (10% on the Schwab and England Activities of Daily Living Scale), disease stage (1 stage on the Hoehn and Yahr Scale), and quality of life (1 SD on the 12-Item Short Form Health Survey).